HIGHVISTA STRATEGIES LLC – Celldex Therapeutics, Inc. Transaction History
HIGHVISTA STRATEGIES LLC portfolio value:
$715,000
portfolio value
HIGHVISTA STRATEGIES LLC quarter portfolio value change:
+4.27%
quarter
Celldex Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +13.45% | 3.01K shares | 111K | $28.11 | 25.42K |
| Q2 2022 | share | Decrease | -12.92% | -3.32K shares | -273K | $26.96 | 22.41K |
| Q1 2022 | share | Decrease | -13.79% | -4.11K shares | -277K | $34.06 | 25.73K |
| Q4 2021 | share | Increase | +4.88% | 1.39K shares | -383K | $38.9 | 29.85K |
| Q3 2021 | share | Decrease | -16.01% | -5.42K shares | 404K | $53.99 | 28.46K |
| Q2 2021 | share | Increase | +2.89% | 953 shares | 455K | $33.44 | 33.89K |
| Q1 2021 | share | Decrease | -33.93% | -16.91K shares | -195K | $20.6 | 32.94K |
| Q4 2020 | share | Increase | +11.21% | 5.02K shares | 208K | $17.52 | 49.85K |
| Q3 2020 | share | Increase | 0.00% | 44.82K shares | 665K | $14.83 | 44.82K |